Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-30

FDA Approved: GLIPIZIDE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for glipizide by Actavis Pharma, Inc. under the ANDA pathway, enabling an additional or updated approval for the generic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glipizide (Glipizide)

Snippet

SUPPL AP for GLIPIZIDE (GLIPIZIDE)